MEPIRAPIM
From Infogalactic: the planetary knowledge core
![]() |
|
Systematic (IUPAC) name | |
---|---|
(4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone
|
|
Clinical data | |
Legal status |
|
Identifiers | |
ChemSpider | 30646772 |
Chemical data | |
Formula | C19H27N3O |
Molecular mass | 349.9 g/mol |
|
|
|
MEPIRAPIM is a indole-based cannabinoid which differs from JWH-018 by having a 4-methylpiperazine group in place of the naphthyl group[1] and has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in 2013, alongside FUBIMINA.[2]
Legality
Sweden's public health agency suggested to classify MEPIRAPIM as hazardous substance on November 10, 2014.[3]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Indoles
- Cannabinoids
- Designer drugs
- Piperazines
- Nervous system drug stubs